Stifel Financial’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Buy
215,446
+20,387
+10% +$1.34M 0.01% 841
2026
Q1
$13.9M Sell
195,059
-81,643
-30% -$6.44M 0.01% 789
2025
Q4
$22.7M Sell
276,702
-81,440
-23% -$6.35M 0.02% 589
2025
Q3
$26.9M Sell
358,142
-2,192
-0.6% -$163K 0.02% 530
2025
Q2
$26.7M Buy
360,334
+13,862
+4% +$965K 0.03% 503
2025
Q1
$28M Buy
346,472
+49,981
+17% +$4.3M 0.03% 455
2024
Q4
$23.2M Buy
296,491
+33,567
+13% +$2.85M 0.02% 523
2024
Q3
$24.7M Buy
262,924
+39,094
+17% +$3.28M 0.03% 503
2024
Q2
$17.4M Buy
223,830
+135,532
+153% +$11.1M 0.02% 592
2024
Q1
$8.03M Buy
88,298
+10,160
+13% +$845K 0.01% 899
2023
Q4
$6.04M Sell
78,138
-16,373
-17% -$1.15M 0.01% 1002
2023
Q3
$6.43M Sell
94,511
-4,290
-4% -$312K 0.01% 916
2023
Q2
$8.03M Sell
98,801
-9,952
-9% -$794K 0.01% 808
2023
Q1
$8.92M Buy
+108,753
New +$7.76M 0.01% 734

Other funds holding GEHC

Stifel Financial's GEHC Position: Q2 2026 in Review

Stifel Financial increased its GE HealthCare (GEHC) stake by 10% in Q2 2026, buying an estimated $1.34M and bringing the position to 215,446 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #841.

Stifel Financial first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $28M in Q1 2025. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Stifel Financial held 215,446 shares of GE HealthCare worth $13.8M as of Q2 2026.
  • Stifel Financial bought 20,387 GE HealthCare shares in Q2 2026, an estimated $1.34M.
  • GE HealthCare made up 0.01% of Stifel Financial's portfolio in Q2 2026, its #841 holding.
  • Stifel Financial first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Stifel Financial's GE HealthCare position peaked at $28M in Q1 2025.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.